Axovant Gene Therapies Ltd.

NAS: AXGT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200104289/composite

$

4.67

Change

+0.03 +0.65%

Volume

Volume 7,729

Sep 22, 2020, 5:40 p.m.

Real time quotes

/zigman2/quotes/200104289/composite

Today's close

$ 4.58

$ 4.64

Change

+0.06 +1.31%

Day low

Day high

$4.30

$4.74

Open
Open: 4.63

52 week low

52 week high

$1.41

$7.78

Open

Market cap

$192.16M

Average volume

663,033

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.96

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/axgt

MarketWatch News on AXGT

  1. Axovant Gene Therapies started at outperform with $18 stock price target at SVB Leerink

    8:07 a.m. June 21, 2019

    - Tomi Kilgore

  2. How to spot risky biotech companies and six to avoid now

    6:14 a.m. Jan. 17, 2019

    - Michael Brush

  3. Axovant shares slide 25% premarket after trial fails to meet main goal

    8:26 a.m. Dec. 10, 2018

    - Ciara Linnane

  4. Oxford BioMedica and Axovat enter $842.5 mln licence agreement for Parkinson's treatment

    7:10 a.m. June 6, 2018

    - Ciara Linnane

  5. Axovant shares soar 49% premarket

    7:11 a.m. June 6, 2018

    - Ciara Linnane

  6. Axovant shares slide 14% premarket

    8:40 a.m. Feb. 12, 2018

    - Ciara Linnane

  7. Axovant CEO, COO resign to pursue other opportunities

    8:36 a.m. Feb. 12, 2018

    - Ciara Linnane

  8. Charting the Market

    12:12 a.m. Jan. 13, 2018

    - Barron's Online

  9. Biotech Can Keep Rallying Through The End Of The Year

    11:25 a.m. Oct. 3, 2017

    - Barrons Blogs

  10. Charting the Market

    2:22 a.m. Sept. 30, 2017

    - Barron's Online

  11. How a failed Alzheimer’s drug stung some large hedge funds

    5:25 p.m. Sept. 29, 2017

    - Juliet Chung

  12. Axovant Sciences stock price target cut to $6 from $29 at Baird

    9:26 a.m. Sept. 27, 2017

    - Tomi Kilgore

  13. Axovant Sciences downgraded to neutral from outperform at Baird

    9:26 a.m. Sept. 27, 2017

    - Tomi Kilgore

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/axgt

Other News on AXGT

  1. Axovant (AXGT) Catches Eye: Stock Jumps 12%

    8:56 a.m. Today

    - Zacks.com

  2. 10-Q: AXOVANT GENE THERAPIES LTD.

    6:47 a.m. Aug. 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. AAPL, FB among premarket gainers

    8:26 a.m. July 31, 2020

    - Seeking Alpha

  4. Assessing Axovant Gene Therapies

    2:34 p.m. June 1, 2020

    - Seeking Alpha

  5. Top Ranked Momentum Stocks to Buy for May 5th

    10:55 a.m. May 5, 2020

    - Zacks.com

  6. Benchmark likes Regeneron in premarket analyst action

    7:18 a.m. April 17, 2020

    - Seeking Alpha

  7. Selloff creating bargains in healthcare - Baird

    1:54 p.m. March 25, 2020

    - Seeking Alpha

  8. Daily Insider Ratings Round Up 2/27/20

    12:51 p.m. March 2, 2020

    - Seeking Alpha

  9. VIAC, WIX among premarket losers

    10:17 a.m. Feb. 20, 2020

    - Seeking Alpha

  10. IPO Update: Passage Bio Finalizes $126 Million IPO Plan

    4:57 p.m. Feb. 18, 2020

    - Seeking Alpha

  11. 10-Q: AXOVANT GENE THERAPIES LTD.

    7:49 a.m. Feb. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Loading more headlines...
/news/pressrelease/company/us/axgt

Press Releases on AXGT

  1. Changes in Institutional Ownership: $AXGT $NWGI $VRT

    9:05 a.m. June 11, 2020

    - The Market Signal

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.